Banner Year for Pharma and Biotech M&A

    Among the banner year for mergers and acquisitions that 2014 saw globally, the pharmaceutical and biotech industries emerged as leaders in new deals and 2015 looks to be no different.  Check out this article from Benzinga.com to see how the pharma and...

EU, Zimmer agree to extend review of Biomet merger

    Zimmer has agreed with the European Commission to extend the EuroZone review of its pending, $13.4 billion acquisition of cross-town orthopedics rival Biomet, according to MassDevice.com.  The proposed merger would see Zimmer pay $13.35 billion for...

Medtronic-Covidien Deal to Close Early 2015

  Medtronic will complete the purchase of Covidien in early 2015, according to documents filed with the Securities & Exchange Commission.  At the close of the transaction, the Covidien Group will function with the exception of its Peripheral and Neurovascular...